The data on the duration of use of proton pump inhibitors, the nature and duration of stress, and the timing of the first clinical and instrumentally confirmed manifestations of gastric cancer in 10 patients with chronic non-atrophic gastritis who were treated with proton pump inhibitors both in the form of monotherapy and the composition of standard regimens of H. pylori therapy. It was found that the duration of taking proton pump inhibitors ranged from 2 days to 2 months, and the duration of stress - from 2 years to 45 years. The first clinical manifestations occurred from the 1st to the 5th month after the end of the treatment, and the deterioration of the patients' condition proceeded quickly, “avalanche-like” within 7-10 days.

chronic non-atrophic gastritis, proton pump inhibitors, gastric cancer

Avramenko AA. Dostovernost stul-testa pri testirovanii bolnykh khronicheskim khelikobakteriozom pri nalichii aktivnykh i neaktivnykh form khelikobakternoy infektsii na slizistoy obolochke zheludka. Suchasna gastroyenterologíya. 2014; 3 (77): 22–6. [Russian].

Avramenko A.A. Sluchaj obrazovaniya nedifferencirovannoj formy raka verhnej treti tela – kardialnogo otdela zheludka posle provedeniya standartnoj posledovatelnoj antihelikobakternoj terapii. Klinichna ta eksperimentalna patologiya. 2014; 3 (49): 242 - 244. [Russian].

Avramenko AA, Gozhenko AI, Goydyk VS, editors. Yаzvennaya bolezn (ocherki klinicheskoy patofiziologii). Odessa : OOO «RA «ART-V», 2008. 304 s. [Russian].

Avramenko A.O., Gozhenko A.I., Shuhtina I.M. Vpliv vnutrishnoklitinnogo «depo» gelikobakternoyi infekciyi na formuvannya atrofichnih zmin u zalozah slizovoyi shlunku. Biomedical and Biosocial Anthropology. 2011;16: 83-85. [Ukrainian].

Bezdetko N.V. Rabeprazol: novoe ob izvestnom. Suchasna gastroenterologiya. 2016; 4(90): 51-59. [Russian].

Butenko G.M., Tereshina O.P. Stress i immunitet. Mezhdunarodnyj medicinskij zhurnal.2001; 3: 91-94. [Russian].

Buharin T.V., Yakovenko V.A., Kurik E.G. Vozmozhnost prognozirovaniya gistologicheskogo tipa adenokarcinomy pri ispolzovanii endoskopov s bolshoj razreshayushej sposobnostyu v rezhimah bolshogo uvelicheniya i uzkopolosnoj vizualizacii. Ukrayinskij zhurnal maloinvazivnoyi ta endoskopichnoyi hirurgiyi. 2016; 3: 31 – 34. [Russian].

Vinnik Yu.A., Oleksenko V.V., Efetov S.V., Zaharov V.A. Rekonstruktivno-vosstanovitelnyj etap gastrektomii pri rake proksimalnogo otdela zheludka. Hirurgiya. 2013;12: 11 – 17. [Russian].

Vinnik Yu.O., Trunov G.V., Mohamed Sayed Abuhassan Rentgenologichna ocinka novogo metodu rekonstrukciyi travnogo traktu pislya gastrektomiyi. Klinichna ta eksperimentalna patologiya.2016; 4 (58): 32 - 37. [Ukrainian].

Zak M.Yu., Pasiyeshvili L.M., Kuznecov G.E. Endoskopichni zmini slizovoyi obolonki ezofagogastroduodenalnoyi zoni u hvorih na atrofichnij gastrit u poyednanni z osteoartrozom. Klinichna ta eksperimentalna patologiya. 2016; 3 (57): 39 - 46. [Ukrainian].

Ingibitory protonnoj pompy povyshayut risk razvitiya raka zheludka. https://tlv.hospital/translated-medic-world-news/ingibitory-protonnoy-pompy-povyshayut-risk-razvitiya-raka-zheludka. [Russian].

Kímakovich VY, Nikishaev VI, editors. Yendoskopiya travnogo kanalu. Norma, patologiya, suchasni klasifikatsiyi. Lviv: Vidavnitstvo Meditsina Svítu, 2008. 208 s., il. 4. [Ukrainian].

Kozij M.S., Grishenko G.V., Silenko A.A. Dinamika kletochnogo sostava gipofizarno-nadpochechnikovoj sistemy belyh myshej v usloviyah stressa. Ukrayinskij zhurnal medicini,biologiyi ta sportu.2017; 6(8):178 – 182. [Russian].

Korulya Sh.A., Maruhno Sh.S., Gerasimenko O.M. Diagnoz «hronichnij gastrit». Problemni pitannya. Suchasni pidhodi do diagnostiki ta likuvannya. Suchasna gastroenterologiya. 2014; 2(76): 133-138. [Ukrainian].

Nikiforova Ya.V., Tolstova T.N., Cherelyuk N.I. Osnovnye polozheniya Soglasitelnoj konferencii po diagnostike i lecheniyu infekcii Helicobacter pylori – Maastriht V (2015). Suchasna gastroenterologiya. 2016; 6(92): 119-133. [Russian].

Palij I.G., Zayika S.V., Kondratyuk N.M. Rol ingibitoriv protonnoyi pompi v uspishnij eradikaciyi Helicobacter pylori: misce pantoprazolu. Suchasna gastroenterologiya. 2017; 4 (96): 81- 89. [Ukrainian].

Panasenko T.O., Neporada K.S. Zastosuvannya melaninu yak stesprotektora pivkul golovnogo mozku v zalezhnosti vid stresostijkosti tvarin. Tavricheskij mediko-biologicheskij vestnik. 2012; 3 (59): 250 – 253. [Ukrainian].

Patent 93273 Ukraine, MPK G01N 33/48 (2006.01) Sposíb testuvannya gelíkobakternoyi ínfektsii u khvorikh na khronichniy gelikobakterioz / AO Avramenko. № u201403956; zayavl. 14.04.2014; opubl.25.09.2014. Byul. № 18. 3 s. [Ukrainian].

Perederii VG , editors. Yazvennaya bolezn ili pepticheskaya yazva? Kiev, 1997. 158 s. [Russian].

Tkach S.M. Prakticheskie podhody k optimizacii diagnostiki i lecheniya infekcii Helicobacter pylori v Ukraine. Suchasna gastroenterologiya.2018; 1 (99): 74 -79. [Ukrainian].

Topol I.O., Kamishnij O.M. Zmini transkripcijnoyi aktivnosti geniv NRZC1 i ADRB 2 – receptoriv, prozapalnih citokiniv ta NLRP3-inflamasomi v kishkovo-asocijovanij limfoyidnij tkanini shuriv v umovah hronichnogo socialnogo stresu. Klinichna ta eksperimentalna patologiya. 2015; 2 (52): 220-225. [Ukrainian].

Sherbinina M.B. Dlitelnaya kislotosupressiya zheludka ingibitorami protonnoj pompy: vozmozhnye riski, vybor optimalnogo preparata. Suchasna gastroenterologiya. 2017; 1 (93): 59-68. [Russian].

Shuhtina I.N., Avramenko A.A. K voprosu ob iskusstvennyh prichinah formirovaniya vnutrikletochnogo «depo» helikobakternoj infekcii u bolnyh hronicheskim gastritom tipa V. Ukrayinskij medichnij almanah. 2009; 6: 225 – 226. [Russian].

Shuhtina I.N., Gozhenko A.I., Avramenko A.A. K voprosu o estestvennyh prichinah formirovaniya vnutrikletochnogo «depo» helikobakternoj infekcii u bolnyh hronicheskim gastritom tipa V. Aktualnye problemy transportnoj mediciny. 2010; 2 (20): 119 – 122. [Russian].

Khaitov RM, Pinegii BV. Izmenenie immuniteta pri khirurgicheskikh vmeshatelstvakh. Annaly khirurgicheskoi gepatologii. 1998; 2: 100-10. [Russian].

Yanish Yu.V., Artamonova A.B., Zalyetok S.P. Vpliv modulyatoriv metabolizmu argininu i poliaminiv na aktivnist arginazi ta produkciyu oksidiv azotu klitinami ascitnogo raku Erliha in vivo. Klinichna onkologiya. 2016; 3 (23): 89-91. [Ukrainian].

Bradley MC, Murray LJ, Cantwell MM, et al. Proton pump inhibitors and histamine-2-receptor antagonists and pancreatic cancer risk: a nested case-control study. Br J Cancer. 2012; 106: 233-239.

Chubak J, Boudreau DM, Rulyak SJ, et al. Colorectal cancer risk in relation to use of acid suppressive medications. Pharmacoepidemiol Drug Saf. 2009; 18: 540-544.

Henwood M, Clarke PA, Smith AM, et al. Expression of gastrin in developing gastric adenocarcinoma. Br J Surg. 2001; 88: 564-568.

Ho AC, Horton KM, Fishman EK. Gastric carcinoid tumors as a consequence of chronic hypergastrinemia: spiral CT findings. Clin Imaging. 2000; 24: 200-203.

van Soest EM, van Rossum LG, Dieleman JP, et al. Proton pump inhibitors and the risk of colorectal cancer. Am J Gastroenterol. 2008; 103: 966-973.

Waldum HL, Sandvik AK, Brenna E, et al. Gastrin-histamine sequence in the regulation of gastric acid secretion. Gut. 1991; 32: 698-701.